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Urabe/Kanitakis/Thivolet Fig. 1 . Histological findings of Balb/c mouse skin, a Before examination. × 100. b After CsA administration for 10 days (skin taken from the same mouse as in a). × 100. Before treatment, all hair follicles are in the telogen phase. Numerous anagen hairs are observed after CsA administration. Table 1 . Number of anagen hair/cm length of epidermal surface hair germ enveloping the dermal papilla were observed in the dermis and subcutaneous tissue ( fig. lb) . The number of anagen hairs observed was different according to the animal studied (table 1). In control mice, all hair follicles were still in the telogen phase.
In contrast with what occurs in guinea pig and man, the hairs of small mammalian species are replaced not simultaneously but in a patterned sequence [10] . In the male albino rat, hair growth of the first wave, forming the second coat (G2 anagen hair), begins at about 5 weeks of age and is completed at 8 weeks. For the third coat (G3 anagen hair), resting follicles first become active in a limited ventral area at 8.5 weeks of age, and this follicular activation gradually spreads over the whole skin in a wave-like manner during 12-14 weeks [11] . Using this spontaneous hair cycle, Johnson [12] demonstrated that ultraviolet light initiates an active hair growth in telogen skin, and Silver at al. [ 13] carried out comparative studies of mitotic activity in pluckinginduced and spontaneous anagen hairs. The results of our study show that a short treatment (10 days) with CsA activates resting hair follicles and induces anagen hairs. Indeed, histoiogically it was observed that the hair cycle of non-treated Balb/c mice is in the spontaneous telogen phase, while after treatment a dramatic Ciclosporin A Initiates Active Hair Growth in Mice 271 increase in the number of anagen hair occurred. The variation in the number of CsA-induced anagen follicles observed in treated mice may depend on the difference of the drug absorption from the gastrointestinal tract or the variable sensitivity of their hair follicles to CsA. The efficacy of CsA on patients with alopecia areata is known [3] [4] [5] [6] [7] [8] . A recent study demonstrated that the number of hairs observed in the skin of CsA-treated alopecia patients was significantly higher than that in untreated skin, under the condition of grafting onto nude mice [14] . Histologically, telo-gen hairs are present in the lesional skin of alopecia patients [15] . Therefore, this strongly suggests that CsA activates the resting hair follicles and induces the anagen hair growth in the lesional skin of alopecic patients. Furthermore, the mechanism of hypertrichosis observed in nonalopecia patients treated with CsA is also strongly suggested to be the same with that observed in our studies; i.e. hair follicles sensitive to CsA are activated and remain in the anagen phase during treatment. After discontinuation of CsA therapy, their normal (pretreatment) hair cycling pattern may be reestablished. Wysocki and Daley [2] reported that the hair grown in excess in patients is lost soon after the cessation of CsA therapy.
